Article Versions Notes

Yan X, Su Y, Fan X, Chen H, Lu Z, Liu Z, Li Y, Yi M, Zhang G, Gu C, et al. Liraglutide Improves the Angiogenic Capability of EPC and Promotes Ischemic Angiogenesis in Mice under Diabetic Conditions through an Nrf2-Dependent Mechanism. Cells. 2022; 11(23):3821. https://doi.org/10.3390/cells11233821

Yan, Xiaoqing, Yue Su, Xia Fan, Hui Chen, Zixian Lu, Zijuan Liu, Yingjian Li, Mei Yi, Guigui Zhang, Chunjie Gu, and et al. 2022. "Liraglutide Improves the Angiogenic Capability of EPC and Promotes Ischemic Angiogenesis in Mice under Diabetic Conditions through an Nrf2-Dependent Mechanism" Cells 11, no. 23: 3821. https://doi.org/10.3390/cells11233821

Yan, X., Su, Y., Fan, X., Chen, H., Lu, Z., Liu, Z., Li, Y., Yi, M., Zhang, G., Gu, C., Wang, K., Wu, J., Sun, D., Zhang, Y., Zhang, C., Dai, X., & Zheng, C. (2022). Liraglutide Improves the Angiogenic Capability of EPC and Promotes Ischemic Angiogenesis in Mice under Diabetic Conditions through an Nrf2-Dependent Mechanism. Cells, 11(23), 3821. https://doi.org/10.3390/cells11233821